P

Inventor

LUYTEN FRANK

BE9 patents
⚠️ This page may combine multiple inventors who share the name “LUYTEN FRANK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

TIGENIX NV

4 patents
US7485310B2Feb 3, 2009

Use of CXCL6 chemokine in the prevention or repair of cartilage defects

TIGENIX NV24 citations87
US7863045B2Jan 4, 2011

Isolation of skeletal precursor cells

TIGENIX NV0 citations47
US7842502B2Nov 30, 2010

Use of CXCL6 chemokine for inducing precursor cells into chondrocytes

TIGENIX NV0 citations47
US7482114B2Jan 27, 2009

In vivo assay and molecular markers for testing the phenotypic stability of cell populations, and selected cell populations for autologous transplantation

TIGENIX NV1 citations47

UNIV LEUVEN KATH

2 patents
US11278645B2Mar 22, 2022

Engineering functional bone organs

UNIV LEUVEN KATH0 citations46
US11471492B2Oct 18, 2022

Compositions for treatment of osteochondral disorders

UNIV LEUVEN KATH0 citations37

TIGENEX N V

1 patent
US7479367B1Jan 20, 2009

In vivo assay and molecular markers for testing the phenotypic stability of cell populations and selected cell populations for autologous transplantation

TIGENEX N V1 citations42

LEUVEN K U RES & DEV

1 patent
US7371725B2May 13, 2008

Spondyloarthropathies

LEUVEN K U RES & DEV1 citations41

LUYTEN FRANK

1 patent
US9089598B2Jul 28, 2015

Method of treating connective tissue defect using chondrocytes selected for phenotypic stability

LUYTEN FRANK1 citations37